Myeloid Malignancies clinical trials

Explore recruiting myeloid malignancies clinical trials.

Recruiting myeloid malignancies studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Myeloid Malignancies trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1b/2, Open-Label, Dose Finding, and Expansion Study of the Bcl‑2 Inhibitor BGB‑11417 in Patients With Myeloid Malignancies

Spain, France, Germany, Italy

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Safety Study of PF-08046040/SEA-CD70 in Patients with Myeloid Malignancies

Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Study to Evaluate CC-486 in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Cancer Participants

Spain, Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Apixaban/rivaroxaban Versus Aspirin for primary prevention of thrombo-embolic complications in JAK2V617F-positive myeloproliferative neoplasms

France

Phase II and Phase III (Integrated) EU CTIS Study details

Myeloid Malignancies trials by city

Myeloid Malignancies in Toronto Myeloid Malignancies in Vancouver Myeloid Malignancies in Montreal Myeloid Malignancies in Calgary Myeloid Malignancies in Edmonton Myeloid Malignancies in Ottawa Myeloid Malignancies in Winnipeg Myeloid Malignancies in Quebec City Myeloid Malignancies in Hamilton Myeloid Malignancies in Kitchener Myeloid Malignancies in London Myeloid Malignancies in Halifax Myeloid Malignancies in New York Myeloid Malignancies in Los Angeles Myeloid Malignancies in Chicago Myeloid Malignancies in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease